In addition, it was found that circGFRA1 was significantly up-regulated in HER2 positive breast cancer, and silencing circGFRA1 could inhibit the proliferation, invasion and metastasis of HER2 positive breast cancer cells. This evidence concerns the gene ERBB2 and breast carcinoma.